Amgen

Amgen

2w

TIME has named Amgen to its World’s Most Impactful Companies 2026 list. Amgen's positive contributions through its products and services, along with the drive within the company to accomplish its longstanding mission to serve patients are reflected in this recognition. ...Show more

Amgen

1mo

Amgen has been recognized by Newsweek as one of the Most Trustworthy Companies in America 2026. The annual list highlights companies that have built strong relationships and credibility at a time when trust remains a critical factor in business performance and reputation. This recognition reflects the dedication of employees worldwide to Amgen’s mission to serve patients and its continued focus on fighting the world’s toughest diseases. The award was developed by Newsweek in partnership with global research firm Statista and is based on an independent survey of 25,000 U.S. respondents, resulting in more than 100,000 evaluations from consumers, employees and investors. The ranking also incorporated an analysis of online media sentiment....Show more

Amgen

2mo

From customer conversations on the road to moments that truly matter, every day brings a new opportunity to make an impact at Amgen. If you’re looking for a career where your work makes a real difference, explore job opportunities with Amgen and discover where your purpose can take you....Show more

Amgen

3mo

When your work touches the lives of patients around the world, supporting the people behind it matters more than ever. Managers like Aine play a critical role in safeguarding their teams’ safety and wellbeing—enabling the seamless production, packaging, and distribution of life‑changing biologics that reach patients worldwide. Learn more about how we put our people first and our mission to serve patients worldwide....Show more

Amgen

4mo

For decades, the KRAS gene was considered “undruggable”. Christopher helped changed that through his decades of experience in crystallizing and visualizing proteins. His research led to a remarkable opportunity in 2013, when he joined a new effort to re-examine a common, cancer-driving mutation in KRAS. After solving over a hundred covalent KRAS structures, Christopher made a key discovery in “the cryptic pocket.” This moment opened a pathway to design potent, stable inhibitors that could halt the KRAS mutation. In 2025, he and his team received the ACS Heroes of Chemistry award. Christopher’s story of persistence, patience, and teamwork is one of many at Amgen. Discover what you can accomplish with us....Show more